Cargando…

Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies

BACKGROUND: Asphericity (ASP) of the primary tumor’s metabolic tumor volume (MTV) in FDG-PET/CT is independently predictive for survival in patients with non-small cell lung cancer (NSCLC). However, comparability between PET systems may be limited. Therefore, reproducibility of ASP was evaluated at...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogasch, Julian M. M., Furth, Christian, Bluemel, Stephanie, Radojewski, Piotr, Amthauer, Holger, Hofheinz, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606415/
https://www.ncbi.nlm.nih.gov/pubmed/33140213
http://dx.doi.org/10.1186/s13550-020-00725-y
_version_ 1783604478691246080
author Rogasch, Julian M. M.
Furth, Christian
Bluemel, Stephanie
Radojewski, Piotr
Amthauer, Holger
Hofheinz, Frank
author_facet Rogasch, Julian M. M.
Furth, Christian
Bluemel, Stephanie
Radojewski, Piotr
Amthauer, Holger
Hofheinz, Frank
author_sort Rogasch, Julian M. M.
collection PubMed
description BACKGROUND: Asphericity (ASP) of the primary tumor’s metabolic tumor volume (MTV) in FDG-PET/CT is independently predictive for survival in patients with non-small cell lung cancer (NSCLC). However, comparability between PET systems may be limited. Therefore, reproducibility of ASP was evaluated at varying image reconstruction and acquisition times to assess feasibility of ASP assessment in multicenter studies. METHODS: This is a retrospective study of 50 patients with NSCLC (female 20; median age 69 years) undergoing pretherapeutic FDG-PET/CT (median 3.7 MBq/kg; 180 s/bed position). Reconstruction used OSEM with TOF(4/16) (iterations 4; subsets 16; in-plane filter 2.0, 6.4 or 9.5 mm), TOF(4/8) (4 it; 8 ss; filter 2.0/6.0/9.5 mm), PSF + TOF(2/17) (2 it; 17 ss; filter 2.0/7.0/10.0 mm) or Bayesian-penalized likelihood (Q.Clear; beta, 600/1750/4000). Resulting reconstructed spatial resolution (FWHM) was determined from hot sphere inserts of a NEMA IEC phantom. Data with approx. 5-mm FWHM were retrospectively smoothed to achieve 7-mm FWHM. List mode data were rebinned for acquisition times of 120/90/60 s. Threshold-based delineation of primary tumor MTV was followed by evaluation of relative ASP/SUVmax/MTV differences between datasets and resulting proportions of discordantly classified cases. RESULTS: Reconstructed resolution for narrow/medium/wide in-plane filter (or low/medium/high beta) was approx. 5/7/9 mm FWHM. Comparing different pairs of reconstructed resolution between TOF(4/8), PSF + TOF(2/17), Q.Clear and the reference algorithm TOF(4/16), ASP differences was lowest at FWHM of 7 versus 7 mm. Proportions of discordant cases (ASP > 19.5% vs. ≤ 19.5%) were also lowest at 7 mm (TOF(4/8), 2%; PSF + TOF(2/17), 4%; Q.Clear, 10%). Smoothing of 5-mm data to 7-mm FWHM significantly reduced discordant cases (TOF(4/8), 38% reduced to 2%; PSF + TOF(2/17), 12% to 4%; Q.Clear, 10% to 6%), resulting in proportions comparable to original 7-mm data. Shorter acquisition time only increased proportions of discordant cases at < 90 s. CONCLUSIONS: ASP differences were mainly determined by reconstructed spatial resolution, and multicenter studies should aim at comparable FWHM (e.g., 7 mm; determined by in-plane filter width). This reduces discordant cases (high vs. low ASP) to an acceptable proportion for TOF and PSF + TOF of < 5% (Q.Clear: 10%). Data with better resolution (i.e., lower FWHM) could be retrospectively smoothed to the desired FWHM, resulting in a comparable number of discordant cases.
format Online
Article
Text
id pubmed-7606415
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-76064152020-11-04 Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies Rogasch, Julian M. M. Furth, Christian Bluemel, Stephanie Radojewski, Piotr Amthauer, Holger Hofheinz, Frank EJNMMI Res Original Research BACKGROUND: Asphericity (ASP) of the primary tumor’s metabolic tumor volume (MTV) in FDG-PET/CT is independently predictive for survival in patients with non-small cell lung cancer (NSCLC). However, comparability between PET systems may be limited. Therefore, reproducibility of ASP was evaluated at varying image reconstruction and acquisition times to assess feasibility of ASP assessment in multicenter studies. METHODS: This is a retrospective study of 50 patients with NSCLC (female 20; median age 69 years) undergoing pretherapeutic FDG-PET/CT (median 3.7 MBq/kg; 180 s/bed position). Reconstruction used OSEM with TOF(4/16) (iterations 4; subsets 16; in-plane filter 2.0, 6.4 or 9.5 mm), TOF(4/8) (4 it; 8 ss; filter 2.0/6.0/9.5 mm), PSF + TOF(2/17) (2 it; 17 ss; filter 2.0/7.0/10.0 mm) or Bayesian-penalized likelihood (Q.Clear; beta, 600/1750/4000). Resulting reconstructed spatial resolution (FWHM) was determined from hot sphere inserts of a NEMA IEC phantom. Data with approx. 5-mm FWHM were retrospectively smoothed to achieve 7-mm FWHM. List mode data were rebinned for acquisition times of 120/90/60 s. Threshold-based delineation of primary tumor MTV was followed by evaluation of relative ASP/SUVmax/MTV differences between datasets and resulting proportions of discordantly classified cases. RESULTS: Reconstructed resolution for narrow/medium/wide in-plane filter (or low/medium/high beta) was approx. 5/7/9 mm FWHM. Comparing different pairs of reconstructed resolution between TOF(4/8), PSF + TOF(2/17), Q.Clear and the reference algorithm TOF(4/16), ASP differences was lowest at FWHM of 7 versus 7 mm. Proportions of discordant cases (ASP > 19.5% vs. ≤ 19.5%) were also lowest at 7 mm (TOF(4/8), 2%; PSF + TOF(2/17), 4%; Q.Clear, 10%). Smoothing of 5-mm data to 7-mm FWHM significantly reduced discordant cases (TOF(4/8), 38% reduced to 2%; PSF + TOF(2/17), 12% to 4%; Q.Clear, 10% to 6%), resulting in proportions comparable to original 7-mm data. Shorter acquisition time only increased proportions of discordant cases at < 90 s. CONCLUSIONS: ASP differences were mainly determined by reconstructed spatial resolution, and multicenter studies should aim at comparable FWHM (e.g., 7 mm; determined by in-plane filter width). This reduces discordant cases (high vs. low ASP) to an acceptable proportion for TOF and PSF + TOF of < 5% (Q.Clear: 10%). Data with better resolution (i.e., lower FWHM) could be retrospectively smoothed to the desired FWHM, resulting in a comparable number of discordant cases. Springer Berlin Heidelberg 2020-11-02 /pmc/articles/PMC7606415/ /pubmed/33140213 http://dx.doi.org/10.1186/s13550-020-00725-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Rogasch, Julian M. M.
Furth, Christian
Bluemel, Stephanie
Radojewski, Piotr
Amthauer, Holger
Hofheinz, Frank
Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies
title Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies
title_full Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies
title_fullStr Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies
title_full_unstemmed Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies
title_short Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies
title_sort asphericity of tumor fdg uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606415/
https://www.ncbi.nlm.nih.gov/pubmed/33140213
http://dx.doi.org/10.1186/s13550-020-00725-y
work_keys_str_mv AT rogaschjulianmm asphericityoftumorfdguptakeinnonsmallcelllungcancerreproducibilityandimplicationsforharmonizationinmulticenterstudies
AT furthchristian asphericityoftumorfdguptakeinnonsmallcelllungcancerreproducibilityandimplicationsforharmonizationinmulticenterstudies
AT bluemelstephanie asphericityoftumorfdguptakeinnonsmallcelllungcancerreproducibilityandimplicationsforharmonizationinmulticenterstudies
AT radojewskipiotr asphericityoftumorfdguptakeinnonsmallcelllungcancerreproducibilityandimplicationsforharmonizationinmulticenterstudies
AT amthauerholger asphericityoftumorfdguptakeinnonsmallcelllungcancerreproducibilityandimplicationsforharmonizationinmulticenterstudies
AT hofheinzfrank asphericityoftumorfdguptakeinnonsmallcelllungcancerreproducibilityandimplicationsforharmonizationinmulticenterstudies